By Andy Gordon on February 18, 2021
Last week I recommended reusable respirator manufacturer Canopy to you. My reasoning for liking this company goes far beyond meeting growing market demand. Effective masks are not a “nice to have” product. Lives are at risk. Masks are a must-have. But the available N95 masks have major flaws. Masks save lives — but only if the mask is worn and actually works. Enter Canopy. Its respirators — which are N95 alternatives…
By Early Investing on November 3, 2019
In this week’s Mailbag, the Early Investing team explains why altcoins are underperforming and how today’s startup deal flow is better than ever.
By Allison Brickell on June 11, 2018
A quick look at the “vetting pyramid” shows why it’s so important to perform due diligence before investing in startups.